Status:
COMPLETED
Addition of Naltrexone to Methadone Taper
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Conditions:
Heroin Dependence
Opioid-Related Disorders
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
There is a continuing search for more effective opiate detoxification treatments. This study's purpose is to investigate the effects of adding very low doses of naltrexone to a methadone tapering trea...
Detailed Description
Although many different techniques for opiate detoxification exist, the search continues for more effective approaches to reduce the duration and discomfort associated with opioid withdrawal. It has b...
Eligibility Criteria
Inclusion
- Current DSM-IV diagnosis of opiate dependence
- Reads and understands English
Exclusion
- Serious medical disorders (e.g., uncontrolled hypertension, acute or chronic active hepatitis, kidney failure, uncontrolled diabetes)
- Psychiatric conditions that require intensive services (e.g., depression with suicidal ideation, psychosis)
- Mental retardation or other disorder that might limit ability to give informed consent
- Pregnant
Key Trial Info
Start Date :
April 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2006
Estimated Enrollment :
174 Patients enrolled
Trial Details
Trial ID
NCT00135759
Start Date
April 1 2005
End Date
July 1 2006
Last Update
January 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke University
Durham, North Carolina, United States, 27704